Publications: Dr Samar Mohamed Ibrahim Elorbany

Elorbany S, Berlato C, Carnevalli LS, Maniati E, Barry ST, Wang J, Manchanda R, Kzhyshkowska J et al. ( 2024 ) . Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer . Nature Communications vol. 15 , ( 1 )

Elorbany S, Berlato C, Carnevalli L, Barry S, Maniati E, Wang J, Manchanda R, Kzhyshkowska J et al. ( 2024 ) . Abstract 6553: Targeting macrophages and regulatory T cells improves response to chemotherapy in high-grade serous ovarian cancer . Cancer Research . vol. 84 , 6553 - 6553 .

Malacrida B, Elorbany S, Maniati E, Bryan-Ravenscroft R, Skingsley SLP, Laforets F, Manchanda R, Balkwill FR ( 2024 ) . Abstract PR-009: Reconstructing the metastatic tumor microenvironment of high grade serous ovarian cancer using human multicellular in vitro models . Cancer Research . vol. 84 ,

Elorbany S, Malacrida B, Balkwill F ( 2023 ) . Interferon epsilon and ovarian cancer . Trends in Cancer vol. 9 , ( 12 ) 985 - 986 .

Elorbany S, Berlato C, Carnevalli L, Maniati E, Wang J, Barry S, Manchanda R, Kzhyshkowska J et al. ( 2023 ) . Abstract LB195: Immunotherapies that repolarize macrophages and CD4 T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer . Cancer Research . vol. 83 , lb195 - lb195 .

Malacrida B, Elorbany S, Maniati E, Laforets F, Manchanda R, Balkwill FR ( 2023 ) . Abstract 4551: Reconstructing the metastatic tumor microenvironment of high grade serous ovarian cancer: understanding the contribution of malignant cells . Cancer Research . vol. 83 , 4551 - 4551 .

Laforets F, Kotantaki P, Malacrida B, Elorbany S, Manchanda R, Donnadieu E, Balkwill F ( 2023 ) . Abstract 5913: Semi-supervised analysis of myeloid and T cell behavior in ex vivo ovarian tumor slices reveals changes in cell motility after treatments . Cancer Research . vol. 83 , 5913 - 5913 .

Kotantaki P, Laforêts F, Maniati E, Berlato C, Malliouri A, Devlin MJ, Malacrida B, Elorbany S et al. ( 2023 ) . Abstract 5957: Chemotherapy-induced extracellular matrix remodeling in HGSOC . Cancer Research . vol. 83 , 5957 - 5957 .

Laforêts F, Kotantaki P, Malacrida B, Elorbany S, Manchanda R, Donnadieu E, Balkwill F ( 2023 ) . Semi-supervised analysis of myeloid and T cell behavior in ex vivo ovarian tumor slices reveals changes in cell motility after treatments . iScience vol. 26 , ( 4 )

Berlato C, Heath O, Maniati E, Gopinathan G, Kotantaki P, Elorbany S, McDermott J, Pegrum C et al. ( 2021 ) . Abstract 2745: Murine high grade serous ovarian cancer (HGSOC) models replicate the human tumor microenvironment and suggest anti-tumor activities of macrophages after chemotherapy . Cancer Research . vol. 81 , 2745 - 2745 .

Heath O, Berlato C, Maniati E, Lakhani A, Pegrum C, Kotantaki P, Elorbany S, Böhm S et al. ( 2021 ) . Chemotherapy Induces Tumor-Associated Macrophages that Aid Adaptive Immune Responses in Ovarian Cancer . Cancer Immunology Research vol. 9 , ( 6 ) 665 - 681 .

Berlato C, Heath O, Maniati E, Gopinathan G, Kotantaki P, Elorbany S, McDermott J, Pegrum C et al. ( 2021 ) . Murine high grade serous ovarian cancer (HGSOC) models replicate the human tumor microenvironment and suggest anti-tumor activities of macrophages after chemotherapy . CANCER RESEARCH . vol. 81 ,

Wormald B, Elorbany S, Hanson H, Williams JW, Heenan S, Barton DPJ ( 2018 ) . Sertoli‐Leydig Cell Tumour and DICER1 Mutation: A Case Report and Review of the Literature . Case Reports in Obstetrics and Gynecology vol. 2018 , ( 1 )

Chishti U, Elorbany S, Akhtar M, Williams J, Heenan S, Barton DPJ ( 2018 ) . Genital tuberculosis in a post-menopausal Caucasian woman: a case report . Journal of Obstetrics and Gynaecology vol. 39 , ( 2 ) 284 - 285 .

Hellner K, Miranda F, Chedom DF, Herrero-Gonzalez S, Hayden DM, Tearle R, Artibani M, KaramiNejadRanjbar M et al. ( 2016 ) . Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies . EBioMedicine vol. 10 , 137 - 149 .